nimblocity white


nimblocity white


nimblocity white


nimblocity white

Comprehensive Drug Development

Analytical Drug Development - Drug Formulation - GMP Manufacturing


Velesco applies nimblocity to your early phase drug development projects, with our proven formulation of expertise, flexibility, dedication and velocity to clinic.


Expertise and Experience

Velesco is a contract research organization (CRO) providing Chemistry, Manufacturing, and Controls (CMC) services to the pharmaceutical industry. Velesco is founded and staffed by pharmaceutical scientists from Pfizer's former Michigan Research & Development campus. Our team of pharmaceutical company veterans has experience with more than 300 drug development programs.



Our nimble drug development processes and focused pharmaceutical expertise enables us to overcome even the most challenging pharmaceutical development obstacles. Our team is responsive, accommodating and eager to help you reach the full potential of your drug compound, quickly and efficiently.


Nimblocity trademark representing Velesco Pharmaceutical Services’ commitment to be nimble and flexible for pharma manufacturing clients


Personalized Partnerships

We treat your pharmaceutical-development project like it's our own and share everything from insightful observations to solutions for problematic analytical method validation to assistance with the FDA registration process. All of our pharmaceutical consulting services are royalty-free.


Velocity to Clinic

We're committed to getting your compound to the clinic on time. Our size, capacity, and expertise allow us to accommodate changes swiftly while maintaining control and quality.


As experts in pharmaceutical analytical chemistry, drug formulation development, and cGMP clinical supply manufacturing, Velesco pharmaceutical scientists have a proven track record of moving compounds through the critical drug development process with nimblocity and unrivaled success.

News and Events


New Velesco Pharma clinical manufacturing facility begins operations. Read the press release here.

Lisa Crandall, MS, and Peter Angus, PhD, spoke with Pharmaceutical Technology about the best practices in stability testing.  Read the interview here.


                                                                              Velesco has expanded our analytical facilities in a new Wixom, Michigan location with the help of the Bank of Ann Arbor Technology Industry Group.                          Read the press release here.


CEO Dave Barnes has been published in a new Pharmoutsourcing article on Clinical Trial Materials and Manufacturing


2 new job postings! Careers 


Velesco's work published 

  Formulation Development & Manufacturing:

Using a Single Provider Reduces Costs & Risk

Read it here.


Follow Velesco: 

 LinkedIn IN Icon 25px Google+ Follow VelescoPharma on Twitter  FB FindUsOnFacebook 100